⌘K

Login Start Free

Home/Filings/4/0001082038-14-000004

4//SEC Filing

DURECT CORP 4

Accession 0001082038-14-000004

CIK 0001082038operating

View on SEC.gov Company Profile

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 7:32 PM ET

Size

9.3 KB

Accession

0001082038-14-000004

Insider Transaction Report

Form 4

Period: 2014-01-31

DURECT CORPDRRX

Exec. VP Pharm./R&D

Transactions

Award
Non-Qualified Stock Option (right to buy)
2014-01-31+30,380→ 30,380 total
Exercise: $2.09From: 2014-04-30Exp: 2024-01-31→ Common Stock (30,380 underlying)
Award
Incentive Stock Option (right to buy)
2014-01-31+59,620→ 59,620 total
Exercise: $2.09From: 2014-04-30Exp: 2024-01-31→ Common Stock (59,620 underlying)
Award
Non-Qualified Stock Option (right to buy)
2014-01-31+52,042→ 82,422 total
Exercise: $2.09From: 2014-01-31Exp: 2024-01-31→ Common Stock (52,042 underlying)

Footnotes (2)

[F1]ISO/NQ Grants Dated January 31, 2014 combined will vest as follows: one-sixteenth (1/16) of the total shares subject to the option shall vest quarterly over four (4) years following the Grant Date.
[F2]100% of the total shares of this Grant Dated January 31, 2014 shall vest on the Grant Date.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

DURECT CORP

CIK 0001082038

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001082038

Filing Metadata

Form type: 4
Filed: Feb 3, 7:00 PM ET
Accepted: Feb 4, 7:32 PM ET
Size: 9.3 KB

View on SEC.gov